{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T14:30:10Z","timestamp":1784730610695,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.vaccine.2019.04.010","type":"journal-article","created":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T17:50:29Z","timestamp":1556128229000},"page":"3133-3139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Comparison of the immunogenicity of Dukoral\u00ae oral cholera vaccine between renal transplant recipients on either a calcineurin inhibitor or mycophenolate \u2013 A controlled trial"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6104-0688","authenticated-orcid":false,"given":"Emile F.F.","family":"Jonker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein A.C.","family":"Uijlings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3600-9782","authenticated-orcid":false,"given":"Leonardus G.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darius","family":"Soonawala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.04.010_b0005","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/MOT.0b013e3283636c88","article-title":"Immunization in transplantation: review of the recent literature","volume":"18","author":"Pittet","year":"2013","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.vaccine.2019.04.010_b0010","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.idc.2012.06.003","article-title":"The immunosuppressed traveler","volume":"26","author":"Visser","year":"2012","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.vaccine.2019.04.010_b0015","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/ki.2010.269","article-title":"Maintenance immunosuppressive therapy with everolimus preserves humoral immune responses","volume":"78","author":"Struijk","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.vaccine.2019.04.010_b0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056974","article-title":"Serologic vaccination response after solid organ transplantation: a systematic review","volume":"8","author":"Eckerle","year":"2013","journal-title":"PLoS One"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2019.04.010_b0025","first-page":"S1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","author":"Disease Improving Global Outcomes Transplant Work","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.vaccine.2019.04.010_b0030","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/tid.12368","article-title":"Immunization after renal transplantation: current clinical practice","volume":"17","author":"Struijk","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.010_b0035","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.vaccine.2017.01.048","volume":"35","author":"Croce","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.04.010_b0040","unstructured":"Agency EM. European Public Assessment Report - Dukoral. EMA\/643644\/2014 EMEA\/H\/C\/000476; 2009."},{"key":"10.1016\/j.vaccine.2019.04.010_b0045","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/infdis\/jiv108","article-title":"Immunogenicity of the Bivalent Oral Cholera Vaccine Shanchol in Haitian Adults With HIV Infection","volume":"212","author":"Ivers","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.010_b0050","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.tmaid.2006.05.003","article-title":"Prophylactic immunisation against traveller's diarrhoea caused by enterotoxin-forming strains of Escherichia coli and against cholera: does it make sense and for whom?","volume":"6","author":"Weinke","year":"2008","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.010_b0055","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1128\/CVI.00560-14","article-title":"Safety and immunogenicity of escalating dosages of a single oral administration of peru-15 pCTB, a candidate live, attenuated vaccine against enterotoxigenic Escherichia coli and Vibrio cholerae","volume":"22","author":"Chen","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2019.04.010_b0060","first-page":"CD009029","article-title":"Qadri F. Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea","author":"Ahmed","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2019.04.010_b0065","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/tid.12140","article-title":"Seroconversion of 2009 pandemic influenza A (H1N1) vaccination in kidney transplant patients and the influence of different risk factors","volume":"15","author":"Azevedo","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.010_b0070","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/ki.2012.106","article-title":"Mycophenolate and lower graft function reduce the seroresponse of kidney transplant recipients to pandemic H1N1 vaccination","volume":"82","author":"Mulley","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.vaccine.2019.04.010_b0075","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1093\/cid\/cix1039","article-title":"Immunogenicity and protection from a single dose of internationally available killed oral cholera vaccine: a systematic review and metaanalysis","volume":"66","author":"Lopez","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.010_b0080","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/0035-9203(95)90103-5","article-title":"Immunological response to Vibrio cholerae O1 infection and an oral cholera vaccine among Peruvians","volume":"89","author":"Sanchez","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2019.04.010_b0085","unstructured":"Agency EM. Summary of Product Characteristics - Dukoral. EU\/1\/03\/263\/001-003; 2004."},{"key":"10.1016\/j.vaccine.2019.04.010_b0090","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1128\/CVI.00378-14","article-title":"Critical analysis of compositions and protective efficacies of oral killed cholera vaccines","volume":"21","author":"Kabir","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2019.04.010_b0095","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1111\/j.1600-6143.2007.01869.x","article-title":"The effect of sirolimus therapy on vaccine responses in transplant recipients","volume":"7","author":"Willcocks","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.vaccine.2019.04.010_b0100","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/152692480401400410","article-title":"Influenza vaccine antibody responses in lung transplant recipients","volume":"14","author":"Hayney","year":"2004","journal-title":"Prog Transplant"},{"key":"10.1016\/j.vaccine.2019.04.010_b0105","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jcv.2015.04.011","article-title":"Considerable decrease in antibodies against hepatitis B surface antigen following kidney transplantation","volume":"68","author":"Moal","year":"2015","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2019.04.010_b0110","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S1473-3099(17)30359-6","article-title":"Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis","volume":"17","author":"Bi","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.010_b0115","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00098-17","article-title":"Antibody-based correlates of protection against cholera analysis of a challenge study in a cholera-naive population","author":"Haney","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2019.04.010_b0120","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1086\/421275","article-title":"Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh","volume":"189","author":"Saha","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.010_b0125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1586\/erv.10.150","article-title":"Vibrio cholerae: lessons for mucosal vaccine design","volume":"10","author":"Bishop","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2019.04.010_b0130","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1016\/j.vaccine.2007.01.043","article-title":"Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study","volume":"25","author":"McKenzie","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.04.010_b0135","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/tid.12217","article-title":"Efficacy and safety of hepatitis A vaccination in kidney transplant recipients","volume":"16","author":"Jeon","year":"2014","journal-title":"Transpl Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19304487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19304487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T10:07:31Z","timestamp":1559038051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19304487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":27,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0264410X19304487"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.010","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the immunogenicity of Dukoral\u00ae oral cholera vaccine between renal transplant recipients on either a calcineurin inhibitor or mycophenolate \u2013 A controlled trial","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}